A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium(Clostridioides) Difficile Infection

Project: Research project

Description

A Double-Blind Placebo-Controlled Phase 2 Study of VE303 for Prevention of Recurrent Clostridium (Clostridioides) Difficile Infection
StatusActive
Effective start/end date8/22/198/30/24

Funding

  • VEDANTA BIOSCIENCES, INC

Fingerprint

Clostridium difficile
Placebos
Infection